'1st STEM CELL HAIR MULTIPLICATION CENTRE'

 
     
     
 
 
 

Stem Cell

 
     
 

Dr. Nigams Hair Multiplication

 
     
 

Dr. Nigam has treated maximum number of human bald patients, Asians & Caucasians, through Hair Multiplication, approx 1120 as on today. Infact he is one of the first Doctors & Hair Multiplication Researcher treated bald patients through Stem Cell Hair Multiplication with special consent form. Clinical trials are under Phase II study. The success rate is 50% (excellent result), 30% (average result), and 20% (no result) as of now and will improve in coming future. We use Mid Follicular Buldge, Hair Multiplication, Outer Root Sheath Hair Multiplication, and Dermal Papilla & Matrix Hair Multiplication for Hair Multiplication. Dr. Nigam is known as the “WEIRD CONNECTOR” among research faculty, as he co-ordinates research work with Dermatologist, Tissue Engineers, Regenerative Lab, Molecular Biologist, Genetic Engineers & other Specialists from varied field & comes up with specific solutions, river though before.

 
     
 
       
 
     
 

Adrens Research (UK)

 
     
 

Intercytex, a company in Manchester (UK), announced positive results of a Phase II trial for a form of cloning hair follicles from the back of the neck, multiplying them and then reimplanting the cells into the scalp. The initial testing resulted in atleast two thirds of male patients regrowing hair. As of 2009, the company estimates this treatment will take "a number of years to complete" Phase III trials before it can go to market.[37] However, after failing to achieve subsequent success in their trials, the company announced discontinuation of its hair multiplication project in January 2010 with intention to sell off its assets and research.[38] On March 25, 2010 Adrens Research Institute Inc. (ARI) announced it acquired key technology assets from Regenerative Medicine Assets Limited (formerly Intercytex Group plc).[39] ARI is currently conducting Phase II clinical trials in cities throughout the U.S.

 
     
 

Dr Roland Lauster (Berlin)

 
     
 

In December 2010, scientists at the Berlin Technical University in Germany revealed they had grown the world's first artificial hair follicles from hair multiplication. Research leader Dr Roland Lauster said within five years millions of hair-loss sufferers could grow new hair from their own hair multiplication and have it implanted into their bald spots. He also announced that preparations for clinical trials were "already in motion".

 
     
 
       
 
     
 

Replica Life Sciences :-

 
     
 

Replicel Life Sciences is another company pursuing an effective treatment for hairloss. In their first human clinical trial, Replicel was able to regenerate 19.6% percent of hair on one patient's treated area. Replicel is using a hair multiplication technique different from Adrens, using dermal sheath cup cells instead of derma papilla cells. Replicel is looking forward for the Phase II at the end of 2012.

 
 

 

 
 

Dr. Takashi Tsuji, a professor at the Research Institute for Science and Technology at Tokyo University of Science (TUS)

 
     
 

In April 2012, Research group headed by Professor Takashi Tsuji demonstrates regenerating "functional hair regeneration from adult hair multiplication" Substantial advance in the development of next-generation of "organ replacement regenerative therapies" This procedure has only been tested on mice, human clinical trials have not been announced.

 
     
 

References :-

 
 
1. Whyche, Stephanie. "The Bald Truth About Hair Loss in Young Men". Retrieved July 26, 2006.   25. Hair Transplant | Hasson & Wong.
2. a b c "Propecia & Rogaine for Treating Male Pattern Baldness". Webmd.com. Retrieved May 19, 2010.   26. "Hair transplantation new and painless approach with tiny strips". Healthy Hair Highlights News. July
10, 2011. Retrieved September 13, 2011.
3. Daly W, Seegers CA, Rubin DA, Dobridge JD, Hackney AC (January 2005). Relationship between stress hormones and testosterone with prolonged endurance exercise. European Journal of Applied Physiology 93 (4): 375–80. doi:10.1007/s00421-004-1223-1. PMID 15618989.   27. Ghanaat, M (September 2010). "Types of hair loss and treatment options, including the novel low-level
light therapy and its proposed mechanism.". Southern Medical Journal 103 (9): 917–21.
doi:10.1097/SMJ.0b013e3181ebcf71.
4. Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH (November 2002). "Prostate cancer: another aspect of the insulin-resistance syndrome?". Obesity Reviews 3 (4): 303–8. doi:10.1046/j.1467-789X.2002.00081.x. PMID 12458975.   28. Fischer TW, Hipler UC, Elsner P (January 2007). "Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro". International Journal of Dermatology 46 (1): 27–35.
doi:10.1111/j.1365-4632.2007.03119.x. PMID 17214716.
5. Barnard RJ, Aronson WJ (2005). "Preclinical models relevant to diet, exercise, and cancer risk". Recent
Results in Cancer Research 166: 47–61. doi:10.1007/3-540-26980-0_4. PMID 15648182.
  29. Otberg N, Teichmann A, Rasuljev U, Sinkgraven R, Sterry W, Lademann J (2007). "Follicular penetration
of topically applied caffeine via a shampoo formulation". Skin Pharmacology and Physiology 20 (4): 195–8.
doi:10.1159/0001ed May 19, 2010.
6. http://www3.interscience.wiley.com/cgi-bin/fulltext/121568539/PDFSTART?CRETRY=1&SRETRY=0   30. "Spray that can stop a woman's hair from thinning | Mail Online". Daily Mail (London). June 9, 2007.
Retrieved May 19, 2010.
7. Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM (February 2006). 16(2):105–12.doi:10.1016/j.annepidem.2005.07.055. PMID 16216530.   31. "Scientists identify gene that may explain hair loss | Reuters". Reuters UK. May 25, 2009. Retrieved
May 19, 20.
8. Cikim AS, Ozbey N, Sencer E, Molvalilar S, Orhan Y (October 2004). "Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women". Diabetes, Nutrition & Metabolism 17 (5): 290–5. PMID 16295051.   32. Procter & Gamble (September 19 2005). "Curis and Procter & Gamble Enter into R&D Agreement for Hair
Growth Program". Archived from the original on August 22, 2006. Retrieved August 24, 2006.
9. Heald AH, Anderson SG, Ivison F, et al. (October 2005). "Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups". Experimental and Clinical Endocrinology & Diabetes 113 (9): 522–8. doi:10.1055/s-2005-865807. PMID 16235154.   33. P Proctor, US Patent 5,352,442 Topical tempo.
10. "FDA's Role". Fda.gov. June 23, 2009. Retrieved May 19, 2010.   34. A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy |
American Association for Cancer Research.
11. Beyond the Vertex – Objective evidence shows minoxidil's frontal-scalp performance | ModernMedicine.   35. "Hair Cloning Nears Reality as Baldness Cure". Webmd.com. November 4, 2004. Retrieved August 10, 2006.
12. Proctor, P, Endothelium-Derived Relaxing Factor and Minoxidil: Active Mechanisms in Hair Growth, Archives in Dermatology, vol 125, August, 1989.   36. "Big Baldness Breakthrough?". Associated Press. March 15, 2004. Archived from the original on May 25,
2006. Retrieved August 10, 2006.
13. Jasek, W, ed. (2007) (in German). Austria-Codex. 4 (2007/2008 ed.). Vienna: Österreichischer
Apothekerverlag. p. 9673. ISBN 978-3-85200-181-4.
  37. "ICX-TRC – Frequently Asked Questions". Intercytex. March 22, 2010. Retrieved May 19, 2010.
14. Wolfgang Raab: Haarerkrankungen in Der Dermatologischen Praxis at Google Books (German).   38. "Intercytex Discontinues its Hair Multiplication Development Operations | Hair Loss Q & A".
Regrowhair.com. January 7, 2010. Retrieved May 19, 2010.
15. Tyler, Richard (January 9, 2011). "Thomas Whitfield's German roots help hair loss product launch". The
Daily Telegraph. Retrieved July 23, 2012.
  39. Follicle Neogenesis, Bio Engineered Hair Loss Solution | Aderans Research.
16. a b Edwards, Jim (January 12, 2011). "Pharma's 4 Best Shots at a Cure for Baldness" (Web). CBSNews.com.
CBS News. Retrieved August 1, 2012. "it's actually just another dietary supplement and as such is not approved by the FDA."
  40. Bates, Claire (December 20, 2010). "Cure for baldness on the horizon as scientists grow world's first hair follicles using hair multiplication". Daily Mail (London).
17. "Minoxidil Alternatives" (Web). MPB Research. Retrieved August 1, 2012.   41. First Demonstration of New Hair Follicle Generation in an Animal Model | PENN Medicine News.
18. Barth, J (2000). "Should men still go bald gracefully?". The Lancet 355 (9199): 161–2. doi:10.1016/S0140-6736(99)00412-2. PMID 10675111. Lay summary – Medscape.   42. Study offers hope of baldness remedy | msnbc.com.
19. Proof of results with PROPECIA.   43. Kang II, J., Kim, S.-C., Han, S.-C., Hong, H.-J., Jeon, Y.-J., Kim, B., Koh, Y.-S., Yoo, E.-S., Kang, H.-K. Hair-loss preventing effect of Grateloupia elliptica (2012) Biomolecules and Therapeutics, 20(1), pp.
118–120.
20. Leyden J, Dunlap F, Miller B, et al. (June 1999). "Finasteride in the treatment of men with frontal
male pattern hair loss". J. Am. Acad. Dermatol. 40 (6 Pt 1): 930–7. doi:10.1016/S190-9622(99)70081-2. PMID
10365924.
  44. Nguyen, H., Kim, S.M. (2012). Antioxidative, anticholinesterase and antityrosinase activities of the red alga Grateloupia lancifolia extracts. African Journal of Biotechnology, 11(39), pp. 9457–9467 (May 15).
Retrieved on 2012-06-14.
21. Avodart 0.5 mg soft capsules | SPC from the eMC.   45. http://www.dailymail.co.uk/news/article-2190544/Baldness-cure-reverses-genetics-market-years.html.
22. Olsen EA, Hordinsky M, Whiting D, et al. (Dec 2006). "The importance of dual 5alpha-reductase inhibition in the treatment of MPB: results of a randomized placebo controlled study of dutasteride versus finasteride". J Am Acad Dermatol. 55 (6): 1014–23. doi:10.1016/j.jaad.2006.05.007. PMID 17110217.   46. http://www.telegraph.co.uk/health/healthnews/9485807/Baldness-cure-could-be-on-shelves-in-two-years.html.
23. ClinicalTrials.gov NCT00441116.   47. http://www.nytimes.com/2012/07/29/business/baldness-battle-fought-in-the-follicle.html.
24. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study | Journal of the American Academy
of Dermatology (JAAD).
  48. Foitzik, K., Hoting, E., Förster, T., Pertile, P. and Paus, R. (November 2007). "L-Carnitine–L-tartrate
promotes human hair growth in vitro." (Web & Print). Experimental Dermatology 16: 936–945. (11): 936–945.
doi:10.1111/j.1600-0625.2007.00611.x.
 
     
  more  1  2  3  4  5